Gene Therapy Market Worth $17.2 Billion by 2027 - Exclusive Report by MarketsandMarkets™
In May 2022, Novartis AG (Switzerland) received FDA approval for KYMRIAH for adult patients with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy.
View full press release